Vicarious Surgical Inc
NYSE:RBOT
Relative Value
The Relative Value of one RBOT stock under the Base Case scenario is 4.559 USD. Compared to the current market price of 0.541 USD, Vicarious Surgical Inc is Undervalued by 88%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
RBOT Competitors Multiples
Vicarious Surgical Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
V
|
Vicarious Surgical Inc
NYSE:RBOT
|
3.9m USD | 0.4 | -0.2 | 0.2 | 0.2 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
190.9B USD | 4.3 | 29.3 | 16.8 | 23 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.7B USD | 17.1 | 60.1 | 45.6 | 56 | |
| US |
|
Stryker Corp
NYSE:SYK
|
133.7B USD | 5.3 | 41.2 | 21 | 25.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
113.2B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
103.5B USD | 5.2 | 35.7 | 21 | 28.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
43B EUR | 1.9 | 20.4 | 11.4 | 16.1 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 8 | 45.2 | 24.9 | 27.3 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.7B USD | 10.9 | 44.1 | 31.3 | 34.6 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
45.6B USD | 2.1 | 26 | 10.2 | 17.2 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.6B USD | 6.2 | 22.6 | 15.9 | 17.7 |